Citation Impact
Citing Papers
Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir
2008
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Ocular graft-versus-host disease
2012
Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: Risk factors and survival
2000
Weight loss and malnutrition in patients with chronic graft-versus-host disease
2002
TFOS DEWS II Diagnostic Methodology report
2017 Standout
A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease
2001
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
TFOS DEWS II pathophysiology report
2017 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation
2005
Chronic graft-versus-host disease: A prospective cohort study
2003
Chronic graft-versus-host disease
2003 Standout
TFOS DEWS II Epidemiology Report
2017 Standout
Thalidomide for the Treatment of Chronic Graft-versus-Host Disease
1992
Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease
2007
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease
2002
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
2004
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival
1999
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
2003
Health, Functional Status, and Employment of Adult Survivors of Bone Marrow Transplantation
1991
Hematopoietic Stem-Cell Transplantation
2006 Standout
Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease
2001
TFOS DEWS II Management and Therapy Report
2017 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Bone Marrow Transplantation
1994
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Anterior Segment and External Ocular Disorders Associated with Human Immunodeficiency Virus Disease
2007
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Development of a prognostic model for grading chronic graft-versus-host disease
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant
2003
Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing
2013
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
2002
Granulocyte–colony-stimulating factor (G-CSF)–primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF–mobilized peripheral blood stem cells
2001
Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis
1998
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation
1998
Graft-vs.-Host Disease
1997
Duration of immunosuppressive treatment for chronic graft-versus-host disease
2004
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation
1990
Antiviral Drug Resistance of Human Cytomegalovirus
2010
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
2003
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
How I treat chronic graft-versus-host disease
2001
Novel therapeutics for the treatment of graft-versus-host disease
2002
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
1991
Works of D A Jabs being referenced
Change over Time in Incidence of Ganciclovir Resistance in Patients with Cytomegalovirus Retinitis
2007
The OcuBar Manifestations of Graft-Versus-Host Disease
1997
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
1989
Ocular manifestations of HIV infection
1996